Elsevier Inc.

SHERPA: Unknown

People

  1. Abu-Rustum
    Abu-Rustum
  2. Chi
    Chi
  3. Lee
    Lee
  4. Giralt
    Giralt
  5. Mulhall
    Mulhall
  6. Perales
    Perales
  7. Sonoda
    Sonoda
  8. Leitao
    Leitao
  9. Yorke
    Yorke
  10. Wu
    Wu

Groups

  1. Department of Medicine (4608)
  2. Surgery (3547)
  3. Survivorship Research (2657)
  4. Solid Tumor Oncology Division (2651)
  5. Radiation Oncology, Department of (2122)
  6. GSK Faculty (1936)
  7. Center for Hematologic Malignancies (1671)
  8. Hematologic Malignancies, Division of (1608)
  9. Gynecology Disease Management Team (1426)
  10. Sloan Kettering Institute Faculty (1398)
Search Within
Formats
  1. Journal Article (7381)
  2. Meeting Abstract (4692)
  3. Review (615)
  4. Book Section (538)
  5. Editorial (250)
  6. Conference Paper (138)
  7. Correspondence (92)
  8. Guidelines (82)
  9. Research Letter (29)
  10. Miscellaneous (15)
  11. Book Whole (14)
Groups
  1. Department of Medicine (4608)
  2. Surgery (3547)
  3. Survivorship Research (2657)
  4. Solid Tumor Oncology Division (2651)
  5. Radiation Oncology, Department of (2122)
  6. GSK Faculty (1936)

More Groups

People
  1. Nadeem Abu-Rustum (464)
  2. Dennis Chi (420)
  3. Nancy Lee (409)
  4. Michael Zelefsky (401)
  5. Sergio Giralt (384)
  6. John Mulhall (377)

More People

Years
  1. 2025 (243)
  2. 2024 (783)
  3. 2023 (760)
  4. 2022 (794)
  5. 2021 (723)
  6. 2020 (714)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2611)
  2. Gynecologic Oncology (1197)
  3. Journal of Thoracic Oncology (967)
  4. Biology of Blood and Marrow Transplantation (815)
  5. European Journal of Cancer (525)
  6. Journal of Sexual Medicine (435)

More Publications

Results (13846)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Circulating cell-free DNA in patients with newly diagnosed and recurrent cervical cancer
    Meeting Abstract

    Kim, S. H.; Wu, M.; Stylianou, A.; Ghafoor, S.; Lakhman, Y.; Park, K. J.; Leitao, M. M. Jr; Sonoda, Y.; Gardner, G. J.; Broach, V.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG Oncology/GOG study
    Meeting Abstract

    Bae-Jump, V. L.; Sill, M.; Gehrig, P. A.; Moxley, K.; Hagemann, A. R.; Waggoner, S. E.; O'Cearbhaill, R. E.; McDonald, M.; DiSilvestro, P. A.; Sperduto, P.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Tolerability and adverse events experienced by women with ovarian cancer treated with intravenous or intraperitoneal chemotherapy plus veliparib and bevacizumab based on BRCA status
    Meeting Abstract

    Gillen, J.; Miller, A.; Moore, K. N.; Bell-McGuinn, K. M.; Schilder, R.; Walker, J. L.; Brady, W. E.; O'Cearbhaill, R. E.; Guntupalli, S. R.; Armstrong, D. K.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Outcomes based on treatment regimen in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer receiving intravenous or intraperitoneal platinum-based chemotherapy in combination with veliparib and bevacizumab
    Meeting Abstract

    Washington, C. R.; Miller, A.; Moore, K. N.; Bell-McGuinn, K. M.; Schilder, R.; Walker, J. L.; Brady, W. E.; O'Cearbhaill, R. E.; Guntupalli, S. R.; Armstrong, D. K.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • TPX-0005 (Repotrectinib), a next-generation ALK/ROS1/NTRK1-3 inhibitor, has potent antiproliferative and anti-tumor activity as monotherapy and in combination with chemotherapy in neuroblastoma cell lines and pediatric patient derived xenograft models
    Meeting Abstract

    O'Donohue, T.; Ibáñez, G.; Mauguen, A.; Siddiquee, A.; Rosales, N.; Calder, P.; Ndengu, A.; Roberts, S.; Dela Cruz, F.; Kung, A.
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Combined SHP2 and MEK inhibition is effective in models of NF1-deficient malignant peripheral nerve sheath tumors
    Meeting Abstract

    Wang, J.; Pollard, K.; Allen, A.; Tomar, T.; Pijnenburg, D.; Yao, Z.; Rodriguez, F.; Pratilas, C.
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Inhibiting eIF4A in liposarcoma to identify key regulators using ribosome profiling
    Meeting Abstract

    Mohan, P.; Kim, Y. M.
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Radiotherapy as an alternative treatment for inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: Results of GROINSS-V II
    Meeting Abstract

    van Der Zee, A. G.; Slomovitz, B.; Covens, A. L.; van Der Velden, J.; de Hullu, J. A.; Slangen, B.; van Dorst, E.; Van Driel, W. J.; Hermans, R.; Vergote, I. B.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • A pilot study of nivolumab in combination with front-line neoadjuvant dose-dense paclitaxel and carboplatin chemotherapy in patients with high-grade serous ovarian cancer
    Meeting Abstract

    Friedman, C. F.; Snyder, A.; Abu-Rustum, N. R.; Broach, V.; Brown, C. L.; Bykov, Y.; Cadoo, K. A.; Chi, D. S.; Cohen, S.; Eid, K. T.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Interim results from a phase 1/2 precision medicine study of PLX8394-a next generation BRAF inhibitor
    Meeting Abstract

    Janku, F.; Sherman, E. J.; Parikh, A. R.; Feun, L. G.; Tsai, F.; Allen, E.; Zhang, C.; Severson, P.; Inokuchi, K.; Walling, J.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save